HDT Bio Corp.

États‑Unis d’Amérique

 
Quantité totale PI 45
Rang # Quantité totale PI 30 775
Note d'activité PI 2,7/5.0    67
Rang # Activité PI 10 642
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

23 3
7 0
12 0
0
 
Dernier brevet 2024 - Compositions and methods for mul...
Premier brevet 2019 - Conjugatable desmoglein 2 (dsg2)...
Dernière marque 2022 - LION
Première marque 2022 - LION

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions and methods for multivalent immune responses. The disclosure provides nanoparticle ...
Invention Compositions and methods for enhanced antigen binding proteins. The disclosure provides nanopart...
Invention Nucleic acid sensor agonist compositions and uses thereof. The disclosure provides nanoparticle ...
Invention Sars-cov-2 rna vaccine compositions and methods of use. The disclosure provides compositions, me...
Invention Compositions and methods for enhanced protein production. The disclosure provides nanoparticle a...
Invention Rna vaccines against infectious diseases. The disclosure provides compositions, methods of treat...
Invention Dried nanoparticle compositions. Provided herein are dried compositions and methods for preparin...
Invention Cancer therapy compositions and uses thereof. The disclosure provides compositions, methods of t...
Invention Nanoparticle complexes for enhanced safety. The disclosure provides compositions, methods of trea...
2023 Invention Compositions and methods for delivery of rna. The disclosure provides nanoemulsion compositions a...
Invention Immune system modulators and uses thereof. The disclosure provides compositions, methods of treat...
Invention Compositions and methods for multivalent immune responses. The disclosure provides nanoparticle a...
2022 Invention Compositions and methods for enhanced protein production. The disclosure provides nanoparticle an...
Invention Nucleic acid sensor agonist compositions and uses thereof. The disclosure provides nanoparticle c...
Invention Compositions and methods for enhanced antigen binding proteins. The disclosure provides nanoparti...
Invention Cancer therapy compositions and uses thereof. The disclosure provides compositions, methods of tr...
P/S Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents c...
P/S Nanoparticle formulations as components of nucleic acid-based vaccines, medicines, and pharmaceut...
Invention Nucleic acid-small diameter and liquid core nanoparticle complexed compositions. The disclosure p...
Invention Detection of desmoglein-2 in cancers of epithelial origin. The disclosure provides methods of di...
Invention Compositions and methods for delivery of rna-lipid nanoparticle complexes encoding for viral rna ...
Invention Rna vaccines against infectious diseases. The disclosure provides compositions, methods of treatm...
Invention Dried nanoparticle compositions. Provided herein are dried compositions and methods for preparing...
Invention Sars-cov-2 rna vaccine compositions and methods of use. The disclosure provides compositions, met...
2021 Invention Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for v...
Invention Compositions and methods for delivery of rna. The disclosure provides nanoemulsion compositions ...
Invention Rna-lipid nanoparticle complexes of viral rna polymerase region and sars-cov-2 spike protein regi...
Invention Nanoemulsion compositions and methods for delivery of nra. A composition comprising RNA molecules...
2020 Invention Detection of desmoglein-2 in cancers of epithelial origin. The disclosure provides methods of dia...
2019 Invention Conjugatable desmoglein 2 (dsg2) binding proteins and uses therefor. The disclosure provides pol...